Abstract
β-blocker treatment has been proven to improve heart function, morbidity, and survival in patients with systolic heart failure (HF). However, there is limited data addressing the effects of β-blockers in the setting of cocaine use as there is a perceived risk of adverse outcomes from unopposed alpha-receptor activation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
